Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into the interest-rate futures market by launching a new exchange on Monday that’s set to rival the CME Group Inc.
Shares of Biohaven climbed 13% premarket on Monday after the biotech company said its treatment for a rare neurological disorder slowed progress of the condition in a clinical trial.